CORZW (Core Scientific, Inc. Tranche 1 Warrants)
Insider Trading Activity
Every open-market purchase and sale reported by CORZW officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-25 | Adam Taylor Sullivan | Chief Executive Officer | A | — | — |
| 2024-01-25 | Matt Minnis | Director | MIXED | — | — |
| 2024-01-25 | DR KNEELAND YOUNGBLOOD | Director | MIXED | — | — |
| 2024-01-25 | Denise Marie Brucia Sterling | Chief Financial Officer | MIXED | — | — |
| 2024-01-25 | TODD M DUCHENE | See remarks | MIXED | — | — |
| 2024-01-25 | Jarvis V. Hollingsworth | Director | MIXED | — | — |
| 2024-01-25 | Darin Feinstein | Director | MIXED | — | — |
| 2024-01-25 | MICHAEL J LEVITT | Director | MIXED | — | — |
| 2022-12-02 | TODD M DUCHENE | EVP, GC and Secretary | F | — | — |
| 2022-11-02 | TODD M DUCHENE | EVP, GC and Secretary | F | — | — |
| 2022-10-04 | TODD M DUCHENE | EVP, GC and Secretary | F | — | — |
| 2022-09-20 | Brian Neville | Chief Accounting Officer | F | — | — |
| 2022-09-06 | Stacie Olivares | Director | A | — | — |
| 2022-09-06 | TODD M DUCHENE | EVP, GC and Secretary | F | — | — |
| 2022-09-06 | Jarvis V. Hollingsworth | Director | A | — | — |
| 2022-09-06 | DR KNEELAND YOUNGBLOOD | Director | A | — | — |
| 2022-08-26 | TODD M DUCHENE | EVP, GC and Secretary | F | — | — |
| 2022-08-17 | Denise Marie Brucia Sterling | Chief Financial Officer | A | — | — |
| 2022-08-17 | TODD M DUCHENE | EVP, GC and Secretary | A | — | — |
| 2022-08-17 | MICHAEL J LEVITT | Chief Executive Officer | A | — | — |
| 2022-07-07 | MICHAEL J LEVITT | Chief Executive Officer | MIXED | — | — |
| 2022-07-05 | TODD M DUCHENE | EVP, GC and Secretary | F | — | — |
| 2022-06-27 | TODD M DUCHENE | EVP, GC and Secretary | F | — | — |
| 2022-06-27 | Brian Neville | Chief Accounting Officer | F | — | — |
| 2022-06-16 | Denise Marie Brucia Sterling | Chief Financial Officer | MIXED | — | — |
| 2022-06-16 | TODD M DUCHENE | EVP, GC and Secretary | MIXED | — | — |
| 2022-06-16 | Brian Neville | Chief Accounting Officer | MIXED | — | — |
| 2022-06-06 | Darin Feinstein | Chief Vision Officer | Sell | — | — |
| 2022-06-01 | Darin Feinstein | Chief Vision Officer | Sell | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chief Vision Officer | 30,483,592 | — |
| — | Chief Executive Officer | 20,179,833 | — |
| — | See remarks | 3,751,387 | — |
| — | Director | 1,211,956 | — |
| — | Director | 400,038 | — |
| — | Chief Executive Officer | 28,453 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CORZW quote page; the site-wide leaderboard is on the insider transactions hub.